A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
Authors
Keywords
Hypoxia, Cisplatin, Temozolomide, Chemoresistance, CD133, HIFs
Journal
CELLULAR ONCOLOGY
Volume 41, Issue 3, Pages 319-328
Publisher
Springer Nature
Online
2018-02-28
DOI
10.1007/s13402-018-0374-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overcoming therapeutic resistance in glioblastoma: the way forward
- (2017) Satoru Osuka et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma
- (2017) Souvick Roy et al. CELLULAR ONCOLOGY
- Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition
- (2017) Diana Matias et al. CELLULAR ONCOLOGY
- Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways
- (2016) C. Petit et al. BMC CANCER
- Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
- (2016) Mikkel Staberg et al. CELLULAR ONCOLOGY
- BIRC3 is a novel driver of therapeutic resistance in Glioblastoma
- (2016) Dapeng Wang et al. Scientific Reports
- Differential regulation of HIF-1α and HIF-2α in neuroblastoma: Estrogen-related receptor alpha (ERRα) regulates HIF2A transcription and correlates to poor outcome
- (2015) Arash Hamidian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- 3D Porous Chitosan–Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer
- (2015) Kui Wang et al. BIOMACROMOLECULES
- Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
- (2015) Gloria Perazzoli et al. PLoS One
- Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation
- (2014) Laia Capdevila et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of hypoxia on human cancer cell line chemosensitivity
- (2013) Sara Strese et al. BMC CANCER
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype
- (2013) Shaun D. Fouse et al. NEURO-ONCOLOGY
- Hypoxia–Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha
- (2013) Jennifer Adamski et al. PLoS One
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme
- (2013) Marju Kase et al. Radiology and Oncology
- CD133 Is Essential for Glioblastoma Stem Cell Maintenance
- (2013) Paola Brescia et al. STEM CELLS
- What makes cancer stem cell markers different?
- (2013) Uwe Karsten et al. SpringerPlus
- Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications
- (2012) Liuqi Yang et al. EXPERIMENTAL CELL RESEARCH
- The cellular origin for malignant glioma and prospects for clinical advancements
- (2012) Hui Zong et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1
- (2012) Chii-Wen Chou et al. NEURO-ONCOLOGY
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
- (2012) L Persano et al. Cell Death & Disease
- The Hypoxia-Associated Factor Switches Cells from HIF-1 - to HIF-2 -Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion
- (2011) M. Y. Koh et al. CANCER RESEARCH
- Hypoxia Increases Sirtuin 1 Expression in a Hypoxia-inducible Factor-dependent Manner
- (2011) Rui Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High drug attrition rates—where are we going wrong?
- (2011) Lisa Hutchinson et al. Nature Reviews Clinical Oncology
- A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α
- (2010) Sascha Seidel et al. BRAIN
- HIF-1 and HIF-2 transcription factors — Similar but not identical
- (2010) Agnieszka Loboda et al. MOLECULES AND CELLS
- Overexpression of CD133 promotes the phosphorylation of Erk in U87MG human glioblastoma cells
- (2010) Lin Dong et al. NEUROSCIENCE LETTERS
- Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
- (2009) Steven M. Pollard et al. Cell Stem Cell
- MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
- (2009) S. Yip et al. CLINICAL CANCER RESEARCH
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity
- (2008) R. Sullivan et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now